... of the company's stock worth $175,001,000 after buying an additional 3,095,804 shares during the last quarter. Ardsley Advisory Partners grew its stake in TherapeuticsMD by 4,100.0% during the 4th quarter. Ardsley Advisory Partners now owns ...
https://www.americanbankingnews.com/2018/05/07/fy2020-eps-estimates-for-therapeuticsmd-inc-lowered-by-oppenheimer-txmd.html
No comments:
Post a Comment